antibiotic g 418 has been researched along with framycetin in 28 studies
Studies (antibiotic g 418) | Trials (antibiotic g 418) | Recent Studies (post-2010) (antibiotic g 418) | Studies (framycetin) | Trials (framycetin) | Recent Studies (post-2010) (framycetin) |
---|---|---|---|---|---|
515 | 0 | 102 | 8,151 | 460 | 653 |
Protein | Taxonomy | antibiotic g 418 (IC50) | framycetin (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.032 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.032 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.032 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (32.14) | 18.7374 |
1990's | 10 (35.71) | 18.2507 |
2000's | 7 (25.00) | 29.6817 |
2010's | 2 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inaoka, T; Ochi, K; Okamoto, S; Wang, G | 1 |
Aboul-ela, F; Allam, K; Bodoor, K; Boisdore, M; Boyapati, V; Gopu, V; Miller, J; Treleaven, WD; Weldeghiorghis, T | 1 |
Bostock, CJ; Harwood, AJ; Shervington, A | 1 |
Anderson, WF; Crumbleholme, T; Ekhterae, D; Harrison, MR; Karson, E; Zanjani, ED | 1 |
Duch, M; Jørgensen, P; Kjeldgaard, NO; Paludan, K; Pedersen, FS | 1 |
Carman, MD; Gamba-Vitalo, C; Sartorelli, AC | 1 |
Echalier, G; Maisonhaute, C | 1 |
Franke, CA; Hruby, DE; Rice, CM; Strauss, JH | 1 |
Bernstein, A; Dick, JE; Huszar, D; Phillips, RA; Wu, DD | 1 |
Darlington, GJ; Hahn, T; Ledley, FD; Woo, SL | 1 |
Wagman, GH; Weinstein, MJ | 1 |
Byrne, JC; Howley, PM; Law, MF | 1 |
Blam, SB; Kaplan, HS; Riera, FC; Teng, NN | 1 |
Broxmeyer, HE; Cooper, S; Heimfeld, S; Kang, LY; Ruggieri, L; Srivastava, A; Zhou, SZ | 1 |
Kai, N; Kohmura, N; Mishina, M; Sanbo, M; Watanabe, S; Yagi, T; Yasuda, M | 1 |
Giga-Hama, Y; Kumagai, H; Okada, H; Okayama, H; Tohda, H | 1 |
De Crombrugghe, B; Garofalo, S; Lefebvre, V; Metsäranta, M; Vuorio, E; Zhou, G | 1 |
Blanpied, C; Chavanel, G; Goupy, C; Gustafsson, K; Hirsch, F; Hirsch, R; Panczak, A; Poncet, P | 1 |
Campbell, KH; Colman, A; Kind, AJ; Mycock, K; Ritchie, M; Ritchie, WA; Schnieke, AE; Scott, AR; Wilmut, I | 1 |
Bahner, I; King, SR; Kohn, DB; Nabel, GJ; Ranga, U; Verma, S; Woffendin, C; Xu, L; Yang, ZY | 1 |
Bradwin, G; Milstone, DS; Mortensen, RM | 1 |
Bedwell, DM; Keeling, K; Manuvakhova, M | 1 |
Alagón, A; Benatti, U; Boffa, LC; Olvera, A; Ramos, MA; Sánchez, R; Sanchez-Lopez, R; Saralegui, A; Scarfì, S; Stock, RP | 1 |
Hall, EJ; Hopkins, KM; Lieberman, HB; Randers-Pehrson, G; Sawant, SG; Zheng, W | 1 |
Chai, YC; Hoppe, G; Sears, J | 1 |
Chen, X; Jia, S; Liu, F; Sun, D; Zhang, Y | 1 |
Baillie, D; Dupuy, D; Giordano-Santini, R; Johnsen, R; Milstein, S; Svrzikapa, N; Tu, D; Vidal, M | 1 |
Cao, G; Cao, J; Gong, C; Wang, Y; Weng, H; Xue, R; Ye, A; Zhou, W | 1 |
1 review(s) available for antibiotic g 418 and framycetin
Article | Year |
---|---|
Antibiotic from Micromonospora.
Topics: Aminoglycosides; Anti-Bacterial Agents; Chemical Phenomena; Chemistry; Dactinomycin; Erythromycin; Gentamicins; Glycosides; Lactams, Macrocyclic; Leucomycins; Neomycin; Pyrrolidines; Rifamycins; Sisomicin; Streptomycetaceae | 1980 |
27 other study(ies) available for antibiotic g 418 and framycetin
Article | Year |
---|---|
A novel insertion mutation in Streptomyces coelicolor ribosomal S12 protein results in paromomycin resistance and antibiotic overproduction.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Cell-Free System; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Glycine; Green Fluorescent Proteins; Microbial Sensitivity Tests; Molecular Structure; Mutagenesis, Insertional; Paromomycin; Protein Biosynthesis; Ribosomal Proteins; RNA, Bacterial; Sequence Analysis, DNA; Streptomyces coelicolor | 2009 |
Design and implementation of an ribonucleic acid (RNA) directed fragment library.
Topics: Binding Sites; Chemistry, Physical; Databases, Factual; Drug Design; Ligands; Magnetic Resonance Spectroscopy; Molecular Weight; Organic Chemicals; Quality Control; RNA; Small Molecule Libraries | 2009 |
Construction of a neo fusion gene for expression in both prokaryotic and eukaryotic cells.
Topics: Animals; Base Sequence; Drug Resistance, Microbial; Escherichia coli; Gentamicins; Humans; Hypoxanthine Phosphoribosyltransferase; Mice; Molecular Sequence Data; Mutation; Neomycin; Peptide Chain Termination, Translational; Plasmids; Recombinant Fusion Proteins; Selection, Genetic | 1990 |
Retroviral vector-mediated transfer of the bacterial neomycin resistance gene into fetal and adult sheep and human hematopoietic progenitors in vitro.
Topics: Animals; Bone and Bones; Bone Marrow; Colony-Stimulating Factors; Drug Resistance, Microbial; Gene Expression Regulation; Genetic Vectors; Gentamicins; Granulocyte-Macrophage Colony-Stimulating Factor; Growth Substances; Hematopoiesis; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Interleukin-3; Liver; Neomycin; Retroviridae; Sheep; Transfection | 1990 |
Graduated resistance to G418 leads to differential selection of cultured mammalian cells expressing the neo gene.
Topics: Animals; Anti-Bacterial Agents; Cell Division; Cell Line; Clone Cells; Cloning, Molecular; Drug Resistance; Gene Expression; Genetic Vectors; Gentamicins; Kanamycin Kinase; Kinetics; Neomycin; Phosphotransferases | 1989 |
Development of neomycin-resistant WEHI-3B D+ murine cells as an in vivo model of acute nonlymphocytic leukemia.
Topics: Animals; Blotting, Southern; Cell Differentiation; Cell Line; Clone Cells; Disease Models, Animal; Drug Resistance; Female; Gentamicins; Leukemia, Myeloid, Acute; Mice; Mice, Inbred BALB C; Neomycin; Neoplasm Transplantation; Phenotype; Transfection | 1989 |
Stable transformation of Drosophila Kc cells to antibiotic resistance with the bacterial neomycin resistance gene.
Topics: Animals; Anti-Bacterial Agents; Base Sequence; Cell Line; DNA; DNA Restriction Enzymes; Drosophila; Drug Resistance; Drug Resistance, Microbial; Gentamicins; Kanamycin Kinase; Neomycin; Nucleic Acid Hybridization; Phosphotransferases; Plasmids; Transfection | 1986 |
Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Chlorocebus aethiops; DNA Replication; DNA Restriction Enzymes; Drug Resistance, Microbial; Genes, Dominant; Genes, Viral; Gentamicins; Kidney; Neomycin; Plasmids; Recombination, Genetic; Vaccinia virus; Viral Plaque Assay; Virus Replication | 1985 |
High efficiency gene transfer and expression in normal murine B lymphocytes.
Topics: Animals; B-Lymphocytes; Cell Differentiation; Drug Resistance, Microbial; Enhancer Elements, Genetic; Female; Gene Expression Regulation; Genetic Vectors; Gentamicins; Hematopoietic Stem Cells; Hemolytic Plaque Technique; Immunoglobulins; Lipopolysaccharides; Mice; Mice, Inbred CBA; Neomycin; Retroviridae; Transduction, Genetic | 1987 |
Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions.
Topics: Animals; Drug Resistance, Microbial; Gentamicins; Liver; Mice; Neomycin; Phenotype; Phenylalanine Hydroxylase; Retroviridae; Transfection | 1987 |
A stable bovine papillomavirus hybrid plasmid that expresses a dominant selective trait.
Topics: Animals; Bovine papillomavirus 1; Cell Transformation, Viral; DNA Transposable Elements; Drug Resistance, Microbial; Genes, Viral; Genetic Markers; Gentamicins; Mice; Neomycin; Papillomaviridae; Phenotype; Plasmids | 1983 |
Somatic cell hybrid selection with a transfectable dominant marker.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Drug Resistance; Genes, Dominant; Genetic Vectors; Gentamicins; Humans; Hybrid Cells; Hypoxanthine Phosphoribosyltransferase; Mice; Neomycin; Plasmacytoma; Plasmids; Transfection | 1984 |
Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood.
Topics: Antigens, CD; Antigens, CD34; Base Sequence; Blotting, Southern; Cell Division; Colony-Forming Units Assay; Cytokines; Dependovirus; DNA; DNA Primers; Drug Resistance, Microbial; Female; Fetal Blood; Gene Transfer Techniques; Genes, Bacterial; Genetic Vectors; Gentamicins; Hematopoietic Stem Cells; Humans; Molecular Sequence Data; Neomycin; Polymerase Chain Reaction; Pregnancy; Promoter Regions, Genetic; Thymidine Kinase; Virion | 1994 |
Stable production of mutant mice from double gene converted ES cells with puromycin and neomycin.
Topics: Acetyltransferases; Actins; Animals; Base Sequence; Cell Division; Chickens; Chimera; DNA Primers; Embryo, Mammalian; Embryo, Nonmammalian; Female; Genes, myc; Gentamicins; Humans; Male; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Mice, Transgenic; Molecular Sequence Data; Neomycin; Polymerase Chain Reaction; Promoter Regions, Genetic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Proto-Oncogenes; Puromycin; Stem Cells | 1995 |
A copy-number-controlled expression vector for the fission yeast Schizosaccharomyces pombe.
Topics: Annexin A1; Base Sequence; Blotting, Northern; Blotting, Southern; Chloramphenicol O-Acetyltransferase; Cloning, Molecular; Cytomegalovirus; Drug Resistance; Enhancer Elements, Genetic; Gene Expression; Genetic Vectors; Gentamicins; Humans; Kinetics; Molecular Sequence Data; Neomycin; Oligodeoxyribonucleotides; Promoter Regions, Genetic; Recombinant Proteins; Schizosaccharomyces; Simian virus 40; Transcription, Genetic | 1994 |
Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice.
Topics: Animals; Bacterial Proteins; beta-Galactosidase; Cells, Cultured; Collagen; Drug Resistance; Escherichia coli; Gene Expression Regulation; Genes, Reporter; Genes, Synthetic; Gentamicins; Growth Plate; Kanamycin Kinase; Mice; Mice, Transgenic; Neomycin; Phenotype; Phosphotransferases (Alcohol Group Acceptor); Recombinant Fusion Proteins | 1994 |
Antifection: an antibody-mediated method to introduce genes into lymphoid cells in vitro and in vivo.
Topics: Antibodies; Antigens, CD; B-Lymphocytes; beta-Galactosidase; Binding, Competitive; Cell Line; DNA; Drug Resistance; Gentamicins; Immunoconjugates; Lymphoid Tissue; Neomycin; Receptors, Antigen, B-Cell; Spleen; Transfection | 1996 |
Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts.
Topics: Animals; Animals, Genetically Modified; Cloning, Organism; Drug Resistance; Embryo Transfer; Factor IX; Female; Fetus; Fibroblasts; Gentamicins; Humans; Male; Milk; Neomycin; Nuclear Transfer Techniques; Oocytes; Recombinant Proteins; Sheep; Transfection; Transgenes | 1997 |
Gene transfer into human umbilical cord blood-derived CD34+ cells by particle-mediated gene transfer.
Topics: Anti-Bacterial Agents; Antigens, CD34; Blotting, Southern; Cell Differentiation; Cell Separation; Cells, Cultured; Chloramphenicol O-Acetyltransferase; Coculture Techniques; Cytomegalovirus; Drug Resistance; Fetal Blood; Flow Cytometry; Gene Transfer Techniques; Genes, Reporter; Genetic Therapy; Genetic Vectors; Gentamicins; Gold Colloid; Hematopoietic Stem Cells; Humans; Neomycin; Plasmids; Polymerase Chain Reaction; Transfection | 1998 |
Simultaneous Cre catalyzed recombination of two alleles to restore neomycin sensitivity and facilitate homozygous mutations.
Topics: Alleles; Animals; Anti-Bacterial Agents; Cell Line; Cytosine Deaminase; Drug Resistance; Gene Targeting; Genetic Markers; Gentamicins; GTP-Binding Protein alpha Subunit, Gi2; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Proteins; Homozygote; Integrases; Loss of Heterozygosity; Mice; Mutation; Neomycin; Nucleoside Deaminases; Proto-Oncogene Proteins; Receptors, Cytoplasmic and Nuclear; Recombination, Genetic; Thymidine Kinase; Transcription Factors; Viral Proteins | 1999 |
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system.
Topics: Animals; Anti-Bacterial Agents; Cinnamates; Codon, Terminator; Dose-Response Relationship, Drug; Escherichia coli; Genes, Reporter; Gentamicins; Humans; Hygromycin B; Kanamycin; Neomycin; Paromomycin; Plasmids; Protein Biosynthesis; Rabbits; Reticulocytes; Ribosomes; RNA, Messenger; Sisomicin; Streptomycin; Tobramycin | 2000 |
Inhibition of gene expression in Entamoeba histolytica with antisense peptide nucleic acid oligomers.
Topics: Animals; Antisense Elements (Genetics); Biomarkers; Cell Division; Down-Regulation; Entamoeba histolytica; Gentamicins; Golgi Apparatus; Kanamycin Kinase; Membrane Proteins; Microscopy, Fluorescence; Neomycin; Peptide Nucleic Acids; Permeability; Transfection | 2001 |
The radiation-induced bystander effect for clonogenic survival.
Topics: Alpha Particles; Animals; Bystander Effect; Cell Line; Cell Nucleus; Cell Survival; Clone Cells; Cricetinae; DNA; DNA Damage; Drug Resistance; Gentamicins; Neomycin; Transfection | 2002 |
Endogenous oxidoreductase expression is induced by aminoglycosides.
Topics: Aminoglycosides; Cell Line; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Gentamicins; Glutaredoxins; Humans; Hygromycin B; Kanamycin; Neomycin; Oxidation-Reduction; Oxidoreductases; Pigment Epithelium of Eye; Protein Biosynthesis; Reactive Oxygen Species | 2003 |
[Construction of universal vector for gene targeting and analysis of its function].
Topics: Animals; Animals, Genetically Modified; Cloning, Molecular; Ganciclovir; Gene Targeting; Genetic Vectors; Gentamicins; Goats; Integrases; Neomycin; Phosphotransferases | 2008 |
An antibiotic selection marker for nematode transgenesis.
Topics: Animals; Animals, Genetically Modified; Caenorhabditis; Drug Resistance; Genetic Markers; Genetic Vectors; Gentamicins; Neomycin; Selection, Genetic; Transgenes | 2010 |
Germline transformation of the silkworm Bombyx mori L. by sperm-mediated gene transfer.
Topics: Animal Husbandry; Animals; Animals, Genetically Modified; Anti-Bacterial Agents; Bombyx; DNA Transposable Elements; Drug Resistance; Female; Gene Transfer Techniques; Genes, Insect; Gentamicins; Green Fluorescent Proteins; Larva; Male; Neomycin; Nerve Tissue Proteins; Nucleopolyhedroviruses; Recombinant Fusion Proteins; Spermatozoa; Transformation, Genetic | 2012 |